Amanda S. Latham

This study evaluates the neuroprotective effects of PT150, a glucocorticoid receptor modulator, in a rotenone-induced Parkinson's disease mouse model, showing reduced dopaminergic neuron loss and α-synuclein accumulation.

This paper shows that targeting neuroinflammation by down-regulating NF-κB and NLRP3 with SB_NI_112 protects against neurodegeneration in prion disease models.

The paper examines brain pathologies in aging canines with and without cognitive decline, finding that tau hyperphosphorylation at T217 may predict cognitive dysfunction.